Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 257

1.

Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy.

Polichnowski AJ, Licea-Vargas H, Picken M, Long J, Bisla R, Williamson GA, Bidani AK, Griffin KA.

Am J Physiol Renal Physiol. 2015 Nov 1;309(9):F791-9. doi: 10.1152/ajprenal.00211.2015. Epub 2015 Jun 24.

2.

Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression.

Venkatachalam MA, Weinberg JM, Kriz W, Bidani AK.

J Am Soc Nephrol. 2015 Aug;26(8):1765-76. doi: 10.1681/ASN.2015010006. Epub 2015 Mar 25. Review.

3.

Basic science: hypertensive target organ damage.

Bidani AK, Griffin KA.

J Am Soc Hypertens. 2015 Mar;9(3):235-7; quiz 238. doi: 10.1016/j.jash.2015.01.005. Epub 2015 Jan 13. No abstract available.

4.

Hemodynamic basis for the limited renal injury in rats with angiotensin II-induced hypertension.

Polichnowski AJ, Griffin KA, Picken MM, Licea-Vargas H, Long J, Williamson GA, Bidani AK.

Am J Physiol Renal Physiol. 2015 Feb 1;308(3):F252-60. doi: 10.1152/ajprenal.00596.2014. Epub 2014 Dec 4. Erratum in: Am J Physiol Renal Physiol. 2015 Apr 1;308(7):F796. Dosage error in published abstract; MEDLINE/PubMed abstract corrected; Dosage error in article text.

5.

Critical blood pressure threshold dependence of hypertensive injury and repair in a malignant nephrosclerosis model.

Griffin KA, Polichnowski A, Litbarg N, Picken M, Venkatachalam MA, Bidani AK.

Hypertension. 2014 Oct;64(4):801-7. doi: 10.1161/HYPERTENSIONAHA.114.03609. Epub 2014 Jun 23.

6.

Severe renal mass reduction impairs recovery and promotes fibrosis after AKI.

Polichnowski AJ, Lan R, Geng H, Griffin KA, Venkatachalam MA, Bidani AK.

J Am Soc Nephrol. 2014 Jul;25(7):1496-507. doi: 10.1681/ASN.2013040359. Epub 2014 Feb 7.

7.

Blood pressure-renal blood flow relationships in conscious angiotensin II- and phenylephrine-infused rats.

Polichnowski AJ, Griffin KA, Long J, Williamson GA, Bidani AK.

Am J Physiol Renal Physiol. 2013 Oct 1;305(7):F1074-84. doi: 10.1152/ajprenal.00111.2013. Epub 2013 Jul 3.

8.

Renal microvascular dysfunction, hypertension and CKD progression.

Bidani AK, Polichnowski AJ, Loutzenhiser R, Griffin KA.

Curr Opin Nephrol Hypertens. 2013 Jan;22(1):1-9. doi: 10.1097/MNH.0b013e32835b36c1. Review.

9.

Hypertension and chronic kidney disease progression: why the suboptimal outcomes?

Bidani AK, Griffin KA, Epstein M.

Am J Med. 2012 Nov;125(11):1057-62. doi: 10.1016/j.amjmed.2012.04.008. Epub 2012 Aug 17. Review.

10.

PTEN loss defines a TGF-╬▓-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis.

Lan R, Geng H, Polichnowski AJ, Singha PK, Saikumar P, McEwen DG, Griffin KA, Koesters R, Weinberg JM, Bidani AK, Kriz W, Venkatachalam MA.

Am J Physiol Renal Physiol. 2012 May 1;302(9):F1210-23. doi: 10.1152/ajprenal.00660.2011. Epub 2012 Feb 1.

11.

Large BP-dependent and -independent differences in susceptibility to nephropathy after nitric oxide inhibition in Sprague-Dawley rats from two major suppliers.

Griffin K, Polichnowski A, Licea-Vargas H, Picken M, Long J, Williamson G, Bidani A.

Am J Physiol Renal Physiol. 2012 Jan 1;302(1):F173-82. doi: 10.1152/ajprenal.00070.2011. Epub 2011 Sep 21.

12.

Dual protective mechanisms of matrix metalloproteinases 2 and 9 in immune defense against Streptococcus pneumoniae.

Hong JS, Greenlee KJ, Pitchumani R, Lee SH, Song LZ, Shan M, Chang SH, Park PW, Dong C, Werb Z, Bidani A, Corry DB, Kheradmand F.

J Immunol. 2011 Jun 1;186(11):6427-36. doi: 10.4049/jimmunol.1003449. Epub 2011 Apr 20.

13.

Chronic kidney disease: blood-pressure targets in chronic kidney disease.

Bidani AK, Griffin KA.

Nat Rev Nephrol. 2011 Mar;7(3):128-30. doi: 10.1038/nrneph.2010.168. Epub 2010 Dec 21. No abstract available.

14.

More complete renin-angiotensin system blockade: better outcomes or smoke and mirrors.

Bakris GL, Bidani A.

J Hypertens. 2010 Jul;28(7):1382-3. doi: 10.1097/HJH.0b013e328339f971. No abstract available.

PMID:
20574248
15.

Acute kidney injury: a springboard for progression in chronic kidney disease.

Venkatachalam MA, Griffin KA, Lan R, Geng H, Saikumar P, Bidani AK.

Am J Physiol Renal Physiol. 2010 May;298(5):F1078-94. doi: 10.1152/ajprenal.00017.2010. Epub 2010 Mar 3. Review.

16.

Protective importance of the myogenic response in the renal circulation.

Bidani AK, Griffin KA, Williamson G, Wang X, Loutzenhiser R.

Hypertension. 2009 Aug;54(2):393-8. doi: 10.1161/HYPERTENSIONAHA.109.133777. Epub 2009 Jun 22. Review. No abstract available.

17.

Angiotensin II type 2 receptor in chronic kidney disease: the good side of angiotensin II?

Griffin KA, Bidani AK.

Kidney Int. 2009 May;75(10):1006-8. doi: 10.1038/ki.2009.59.

18.

A stable cytosolic expression of VH antibody fragment directed against PVY NIa protein in transgenic potato plant confers partial protection against the virus.

Bouaziz D, Ayadi M, Bidani A, Rouis S, Nouri-Ellouz O, Jellouli R, Drira N, Gargouri-Bouzid R.

Plant Sci. 2009 Apr;176(4):489-96. doi: 10.1016/j.plantsci.2009.01.004. Epub 2009 Jan 20.

PMID:
26493138
19.

Effects of body position on resting lung volume in overweight and mildly to moderately obese subjects.

Benedik PS, Baun MM, Keus L, Jimenez C, Morice R, Bidani A, Meininger JC.

Respir Care. 2009 Mar;54(3):334-9.

20.

Uncritical acceptance of combination treatment of angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor in nondiabetic renal disease trial results.

Griffin KA, Bidani AK.

Hypertension. 2009 Jan;53(1):e3; author reply e4. doi: 10.1161/HYPERTENSIONAHA.108.125062. Epub 2008 Dec 1. No abstract available.

21.

Potential risks of calcium channel blockers in chronic kidney disease.

Griffin KA, Bidani AK.

Curr Cardiol Rep. 2008 Nov;10(6):448-55. Review.

PMID:
18950553
22.

Systolic and mean blood pressures and afferent arteriolar myogenic response dynamics: a modeling approach.

Williamson GA, Loutzenhiser R, Wang X, Griffin K, Bidani AK.

Am J Physiol Regul Integr Comp Physiol. 2008 Nov;295(5):R1502-11. doi: 10.1152/ajpregu.00490.2007. Epub 2008 Aug 6.

23.

Identification of renal Cd36 as a determinant of blood pressure and risk for hypertension.

Pravenec M, Churchill PC, Churchill MC, Viklicky O, Kazdova L, Aitman TJ, Petretto E, Hubner N, Wallace CA, Zimdahl H, Zidek V, Landa V, Dunbar J, Bidani A, Griffin K, Qi N, Maxova M, Kren V, Mlejnek P, Wang J, Kurtz TW.

Nat Genet. 2008 Aug;40(8):952-4. doi: 10.1038/ng.164. Epub 2008 Jun 29.

PMID:
18587397
24.

Adverse renal consequences of obesity.

Griffin KA, Kramer H, Bidani AK.

Am J Physiol Renal Physiol. 2008 Apr;294(4):F685-96. doi: 10.1152/ajprenal.00324.2007. Epub 2008 Jan 30. Review.

25.

Dynamic blood pressure load and nephropathy in the ZSF1 (fa/fa cp) model of type 2 diabetes.

Griffin KA, Abu-Naser M, Abu-Amarah I, Picken M, Williamson GA, Bidani AK.

Am J Physiol Renal Physiol. 2007 Nov;293(5):F1605-13. Epub 2007 Aug 29.

26.

Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade.

Griffin KA, Bidani AK.

Clin J Am Soc Nephrol. 2006 Sep;1(5):1054-65. Epub 2006 Jul 12. Review.

27.

Ultrasound speckle suppression and edge enhancement using multiscale nonlinear wavelet diffusion.

Yue Y, Croitoru MM, Bidani A, Zwischenberger JB, Clark JW.

Conf Proc IEEE Eng Med Biol Soc. 2005;6:6429-32.

PMID:
17281740
28.

Ultrasonic speckle suppression using robust nonlinear wavelet diffusion for LV volume quantification.

Yue Y, Croitoru M, Bidani A, Zwischenberger J, Clark JW Jr.

Conf Proc IEEE Eng Med Biol Soc. 2004;3:1609-12.

PMID:
17272008
29.

A model of the respiratory central pattern generator.

Amini B, Bidani A, Zwischenberger JB, Clark JW Jr.

Conf Proc IEEE Eng Med Biol Soc. 2004;6:4580-3.

PMID:
17271326
30.

Controversy about COOPERATE ABPM trial data.

Bidani A.

Am J Nephrol. 2006;26(6):629, 632; author reply 629-32. No abstract available.

PMID:
17236263
31.

Characterization of dynamics in renal autoregulation using volterra models.

Hacio─člu R, Williamson GA, Abu-Amarah I, Griffin KA, Bidani AK.

IEEE Trans Biomed Eng. 2006 Nov;53(11):2166-76.

PMID:
17073321
32.

The benefits of renin-angiotensin blockade in hypertension are dependent on blood-pressure lowering.

Bidani AK, Griffin KA.

Nat Clin Pract Nephrol. 2006 Oct;2(10):542-3. No abstract available.

PMID:
17003827
33.

Multiscale model for pulmonary oxygen uptake and its application to quantify hypoxemia in hepatopulmonary syndrome.

Chakraborty S, Balakotaiah V, Bidani A.

J Theor Biol. 2007 Jan 21;244(2):190-207. Epub 2006 Aug 2.

PMID:
16973178
34.

Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance.

Bidani AK, Picken M, Hacioglu R, Williamson G, Griffin KA.

Am J Physiol Renal Physiol. 2007 Feb;292(2):F647-54. Epub 2006 Sep 12.

35.
36.

Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms.

Loutzenhiser R, Griffin K, Williamson G, Bidani A.

Am J Physiol Regul Integr Comp Physiol. 2006 May;290(5):R1153-67. Review.

37.

Nonlinear multiscale wavelet diffusion for speckle suppression and edge enhancement in ultrasound images.

Yue Y, Croitoru MM, Bidani A, Zwischenberger JB, Clark JW Jr.

IEEE Trans Med Imaging. 2006 Mar;25(3):297-311.

PMID:
16524086
38.

Systolic blood pressure as the trigger for the renal myogenic response: protective or autoregulatory?

Loutzenhiser R, Griffin KA, Bidani AK.

Curr Opin Nephrol Hypertens. 2006 Jan;15(1):41-9. Review.

PMID:
16340665
39.

Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program.

Kramer H, Luke A, Bidani A, Cao G, Cooper R, McGee D.

Am J Kidney Dis. 2005 Oct;46(4):587-94.

PMID:
16183412
40.

A macrophage cell model for pH and volume regulation.

Luo C, Clark JW Jr, Heming TA, Bidani A.

J Theor Biol. 2006 Jan 21;238(2):449-63. Epub 2005 Jul 25.

PMID:
16043192
41.

A model of the pacemaking neuron of the respiratory central pattern generator.

Amini B, Bidani A, Zwischenberger JB, Clark JW Jr.

IEEE Trans Neural Syst Rehabil Eng. 2005 Jun;13(2):120-4.

PMID:
16003888
42.

Differential effects of salt on renal hemodynamics and potential pressure transmission in stroke-prone and stroke-resistant spontaneously hypertensive rats.

Abu-Amarah I, Bidani AK, Hacioglu R, Williamson GA, Griffin KA.

Am J Physiol Renal Physiol. 2005 Aug;289(2):F305-13. Epub 2005 Apr 12.

43.

[Biventricular thrombus complicating peripartum cardiomyopathy. A case report].

Damorou FJ, Kane A, Napporn G, Thiam O, Bidani A, Diop IB, Sarr M, Ba SA, Diouf SM.

Dakar Med. 2000;45(2):199-201. French.

PMID:
15779186
44.

[Infective endocarditis at the University Hospital of Dakar. Clinical, outcome, and therapeutic features].

Diao M, Kane A, Ba SA, Bidani A, Diop IB, Sarr M, Diouf SM.

Dakar Med. 2001;46(2):105-8. French.

PMID:
15773174
45.

Innate host defense of the lung: effects of lung-lining fluid pH.

Ng AW, Bidani A, Heming TA.

Lung. 2004;182(5):297-317. Review.

PMID:
15742242
46.

Recommendations for blood pressure measurement in animals: summary of an AHA scientific statement from the Council on High Blood Pressure Research, Professional and Public Education Subcommittee.

Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE; AHA Council on High Blood Pressure Research, Professional and Public Education Subcommittee.

Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):478-9. No abstract available.

PMID:
15731487
47.

Recommendations for blood pressure measurement in humans and experimental animals: part 2: blood pressure measurement in experimental animals: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE; Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):e22-33.

PMID:
15731483
48.

A simplified model for V-ATPase H+ extrusion.

Luo C, Clark JW Jr, Heming TA, Bidani A.

IEEE Trans Nanobioscience. 2004 Dec;3(4):257-64.

PMID:
15631137
49.
50.

Pathophysiology of hypertensive renal damage: implications for therapy.

Bidani AK, Griffin KA.

Hypertension. 2004 Nov;44(5):595-601. Epub 2004 Sep 27. Review.

PMID:
15452024

Supplemental Content

Loading ...
Support Center